Risk of recurrence and pregnancy outcomes in young women with breast cancer who do and do not undergo fertility preservation

[1] Fidler MM(2017)Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study Lancet Oncol 18 1579-1589

[2] Gupta S(2012)Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review J Natl Cancer Inst 104 386-405

[3] Soerjomataram I(2018)Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data J Clin Oncol 36 1981-1990

[4] Ferlay J(2021)Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer NPJ Breast Cancer 7 99-270

[5] Steliarova-Foucher E(2010)Measuring ovarian function in young cancer survivors Minerva Endocrinol 35 259-438

[6] Bray F(2019)Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update J Clin Oncol 37 423-1156

[7] Howard-Anderson J(2014)Prospective study of fertility concerns and preservation strategies in young women with breast cancer J Clin Oncol 32 1151-596

[8] Ganz PA(2006)Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer Fertil Steril 86 588-49

[9] Bower JE(2018)The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients Breast 42 41-774

[10] Stanton AL(2018)How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer? Breast Cancer Res Treat 168 773-495

[1] Fidler MM(2017)Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study Lancet Oncol 18 1579-1589

[2] Gupta S(2012)Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review J Natl Cancer Inst 104 386-405

[3] Soerjomataram I(2018)Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data J Clin Oncol 36 1981-1990

[4] Ferlay J(2021)Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer NPJ Breast Cancer 7 99-270

[5] Steliarova-Foucher E(2010)Measuring ovarian function in young cancer survivors Minerva Endocrinol 35 259-438

[6] Bray F(2019)Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update J Clin Oncol 37 423-1156

[7] Howard-Anderson J(2014)Prospective study of fertility concerns and preservation strategies in young women with breast cancer J Clin Oncol 32 1151-596

[8] Ganz PA(2006)Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer Fertil Steril 86 588-49

[9] Bower JE(2018)The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients Breast 42 41-774

[10] Stanton AL(2018)How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer? Breast Cancer Res Treat 168 773-495